Research programme: epilepsy therapeutics - Lundbeck
Alternative Names: Epilepsy therapeutics research programme - LundbeckLatest Information Update: 16 Jul 2016
At a glance
- Originator Lundbeck A/S
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Epilepsy in Denmark
- 20 Oct 2003 Early research in Epilepsy in Denmark (unspecified route)
- 20 Oct 2003 Preclinical trials in Epilepsy in Denmark (unspecified route)